BNT-166c

N/A

Report date: 2026/05/13 09:11:20

Base Information

Drug NameBNT-166c

Drug Alias NameRNA-based Mpox Vaccine (Biontech Se)Monkeypox Vaccines (Biontech Se)RNA-based multivalent vaccine(Biontech Se)Multivalent ribonucleic acid (RNA)-based vaccine(Biontech Se)BNT166c +[6]

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMonkeypox

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiontech Se

China Registration ClassN/A

Develop Information

Active CompaniesBiontech Se

Inactive CompaniesN/A

Active IndicationsMonkeypox

Inactive IndicationsN/A

Other Information

ATC CodeN/A